Electronics makers Samsung and Matsushita will head to court over patents for plasma TVs after Samsung filed a suit accusing the Japanese rival of infringing three of its patents for plasma screen technology.
On the same day as Dutch retailer Royal Ahold NV settled a shareholder class-action suit for $1.1 billion, a sales manager at a Pennsylvania supermarket vendor pled guilty in Manhattan federal court to a conspiracy charge in connection with Ahold’s alleged multimillion-dollar accounting fraud.
A nationally-recognized tax attorney accused of patenting a tax avoidance scheme through inequitable conduct has been slapped once again with a preemptive lawsuit by a major insurance company.
Eager to brandish its coast-to-coast credentials in intellectual property litigation, Philadelphia’s Duane Morris is quickly building a national platform by hiring laterals from competing firms across the U.S.
Former executives of embattled hospital chain HCA Inc. are now not only the subject of a Securities and Exchange Commission investigation, but also of a class action lawsuit alleging they made false statements to inflate the company's stock price.
A Pennsylvania attorney patented a tax avoidance scheme through inequitable conduct, according to insurance provider Travelers Life and Annuity Co., which filed a preemptive lawsuit the same day the patent was granted.
In the most recent development in a court battle that is poised to enter its fourth year, a district court judge denied both the Mylan’s and Pfizer’s requests for summary judgment, sending the drug companies back to court over the patents for $2.5 billion drug Norvasc.
The U.S. patent regime stands on the threshold of the most sweeping reforms in decades, intellectual property attorneys agree. But in a twist, the most dramatic changes will likely come not from Congress, but from the Supreme Court, where a buffet of patent lawsuits awaits consideration for appeal.
A patent attorney, suspended from the USPTO for gross negligence, has appealed his case to the Federal Circuit more than ten years after allegations of misconduct triggered a drawn-out federal lawsuit.
The U.K. House of Lords has upheld a lower court’s decision to invalidate the patent for the key ingredient in GlaxoSmithKline’s Paxil, one of the world’s most widely prescribed antidepressants.
Patent-holding company Rembrandt Vision Technologies LP is suing two eye-care companies for infringing a patent it controls through its intellectual property portfolio.
Copyright and trademark litigator Carole E. Handler has left Thelein Reid to take over as vice chair of the Intellectual Property Litigation Practice Group in Foley & Lardner’s Los Angeles office, Foley & Lardner said.
Futures broker Refco Inc. has placed chief executive Philip Bennett on probation after discovering he owed the company $430 million.
The Securities and Exchange Commission settled its accounting fraud case against Rite Aid Corporation’s former chief legal officer Franklin C. Brown, restricting his future employment opportunities and waiving monetary damages due to his dire financial straights.
In a surprising show of confidence, biotechnology-company Nucleonics Inc. will appeal last Friday’s dismissal of the case brought against it by Benitec Australia, vowing to fight for its day in court to invalidate the patent asserted by its rival.
Only the Securities and Exchange Commission can take legal aim at bonuses received by corporate executives when an accounting scandal leads to a restatement of earnings, according to a much-watched interpretation of the Sarbanes-Oxley Act.
The chairman of the Senate Judiciary Committee has introduced a bill that would crack down on knock-offs and add mandatory destruction provisions to trademark law to fight counterfeiting of manufactured goods.
A federal appeals court has reinstated part of an antitrust challenge to a deal between Irish drug maker Elan and Skyepharma over a generic version of the non-steroidal anti-inflammatory drug Naprelan (naproxen sodium).
United Kingdom-based Smith & Nephew Inc., a global medical device maker, prevailed in the first phase of its patent infringement trial with its Swiss rival Synthes Inc. in district court this week, over technology for aiding the healing of bone fractures.
Two makers of cutting-edge personal handhelds for patient monitoring have settled patent litigation leveled against eTrials Worldwide Inc. by PHT Corporation.